One milestone in glioblastoma therapy was the discovery of the connection between methylation of the MGMT promotor (Hegi et al. 2008, 2009; Kaina et al. 2007) and tumor response to chemotherapy using temozolomide in 2005 (Hegi et al. 2005). Here, MGMT is linked to glioblastoma.